Rocket Pharmaceuticals, Inc. (RCKT): Price and Financial Metrics


Rocket Pharmaceuticals, Inc. (RCKT): $22.50

0.51 (+2.31%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RCKT to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

RCKT Stock Price Chart Interactive Chart >

Price chart for RCKT

RCKT Price/Volume Stats

Current price $22.50 52-week high $23.48
Prev. close $21.99 52-week low $7.57
Day low $22.50 Volume 3,144
Day high $22.50 Avg. volume 754,461
50-day MA $20.10 Dividend yield N/A
200-day MA $15.98 Market Cap 1.70B

Rocket Pharmaceuticals, Inc. (RCKT) Company Bio


Rocket Pharmaceuticals, Inc., formerly Inotek Pharmaceuticals Corporation, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye.


RCKT Latest News Stream


Event/Time News Detail
Loading, please wait...

RCKT Latest Social Stream


Loading social stream, please wait...

View Full RCKT Social Stream

Latest RCKT News From Around the Web

Below are the latest news stories about ROCKET PHARMACEUTICALS INC that investors may wish to consider to help them evaluate RCKT as an investment opportunity.

Rocket Pharmaceuticals (RCKT) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Rocket Pharmaceuticals (RCKT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Yahoo | January 23, 2023

Wall Street Analysts Think Rocket Pharmaceuticals (RCKT) Could Surge 163.35%: Read This Before Placing a Bet

The mean of analysts' price targets for Rocket Pharmaceuticals (RCKT) points to a 163.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Yahoo | January 23, 2023

Rocket Pharmaceuticals Inc. (NASDAQ: RCKT) Fell -9.26% From Highs, What Does The Future Hold?

Rocket Pharmaceuticals Inc. (NASDAQ:RCKT)’s traded shares stood at 1.03 million during the last session, with the company’s beta value hitting 1.22. At the close of trading, the stock’s price was $21.49, to imply an increase of 4.98% or $1.02 in intraday trading. The RCKT share’s 52-week high remains $23.48, putting it -9.26% down since that … Rocket Pharmaceuticals Inc. (NASDAQ: RCKT) Fell -9.26% From Highs, What Does The Future Hold? Read More »

Marketing Sentinel | January 13, 2023

A stock that deserves closer examination: Rocket Pharmaceuticals Inc. (RCKT)

The share price of Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) fell to $18.80 per share on Monday from $19.49. While Rocket Pharmaceuticals Inc. has underperformed by -3.54%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RCKT fell by -10.05%, with highs and lows ranging from $23.48 to $7.57, […]

US Post News | January 10, 2023

Rocket Pharmaceuticals Expands Cardiac Gene Therapy Portfolio with Addition of RP-A601 for PKP2-ACM and Announces Positive Updated Phase 1 Data for RP-A501 in Danon Disease

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic th

Business Wire | January 9, 2023

Read More 'RCKT' Stories Here

RCKT Price Returns

1-mo 17.43%
3-mo 32.28%
6-mo 44.60%
1-year 35.95%
3-year 7.50%
5-year 25.42%
YTD 14.97%
2022 -10.35%
2021 -60.19%
2020 140.95%
2019 53.58%
2018 41.95%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6686 seconds.